An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
Clinical trial NCT04590872 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04590872
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-16
- Primary completion
- 2024-06-03
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.